146 related articles for article (PubMed ID: 38796962)
1. Decoding the role of the CCL2/CCR2 axis in Alzheimer's disease and innovating therapeutic approaches: Keeping All options open.
Arfaei R; Mikaeili N; Daj F; Boroumand A; Kheyri A; Yaraghi P; Shirzad Z; Keshavarz M; Hassanshahi G; Jafarzadeh A; Shahrokhi VM; Khorramdelazad H
Int Immunopharmacol; 2024 Jun; 135():112328. PubMed ID: 38796962
[TBL] [Abstract][Full Text] [Related]
2. Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.
Bose S; Cho J
Arch Pharm Res; 2013 Sep; 36(9):1039-50. PubMed ID: 23771498
[TBL] [Abstract][Full Text] [Related]
3. A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease.
Naert G; Rivest S
J Mol Cell Biol; 2013 Oct; 5(5):284-93. PubMed ID: 23892208
[TBL] [Abstract][Full Text] [Related]
4. Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches.
Moadab F; Khorramdelazad H; Abbasifard M
Life Sci; 2021 Mar; 269():119034. PubMed ID: 33453247
[TBL] [Abstract][Full Text] [Related]
5. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.
Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS
J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease.
Hickman SE; El Khoury J
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):168-73. PubMed ID: 20205643
[TBL] [Abstract][Full Text] [Related]
7. Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.
Ben-Yehuda H; Arad M; Peralta Ramos JM; Sharon E; Castellani G; Ferrera S; Cahalon L; Colaiuta SP; Salame TM; Schwartz M
Mol Neurodegener; 2021 Jun; 16(1):39. PubMed ID: 34172073
[TBL] [Abstract][Full Text] [Related]
8. Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease.
Reale M; Iarlori C; Feliciani C; Gambi D
J Alzheimers Dis; 2008 Jun; 14(2):147-59. PubMed ID: 18560127
[TBL] [Abstract][Full Text] [Related]
9. CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes.
Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Kim K; Eo SK
Immunology; 2016 Oct; 149(2):186-203. PubMed ID: 27260136
[TBL] [Abstract][Full Text] [Related]
10. Chronic pain accelerates cognitive impairment by reducing hippocampal neurogenesis may via CCL2/CCR2 signaling in APP/PS1 mice.
Chen L; Qin Q; Huang P; Cao F; Yin M; Xie Y; Wang W
Brain Res Bull; 2023 Dec; 205():110801. PubMed ID: 37931808
[TBL] [Abstract][Full Text] [Related]
11. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Naert G; Rivest S
J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
[TBL] [Abstract][Full Text] [Related]
12. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
13. Targeting the CCL2-CCR2 axis in depressive disorders.
Curzytek K; Leśkiewicz M
Pharmacol Rep; 2021 Aug; 73(4):1052-1062. PubMed ID: 34031863
[TBL] [Abstract][Full Text] [Related]
14. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.
Xu M; Wang Y; Xia R; Wei Y; Wei X
Cell Prolif; 2021 Oct; 54(10):e13115. PubMed ID: 34464477
[TBL] [Abstract][Full Text] [Related]
15. Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table.
Ranjbar M; Rahimi A; Baghernejadan Z; Ghorbani A; Khorramdelazad H
Int Immunopharmacol; 2022 Dec; 113(Pt A):109325. PubMed ID: 36252475
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation via evoking microglia activation.
Xu J; Dong H; Qian Q; Zhang X; Wang Y; Jin W; Qian Y
Behav Brain Res; 2017 Aug; 332():145-153. PubMed ID: 28587818
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling.
Cazareth J; Guyon A; Heurteaux C; Chabry J; Petit-Paitel A
J Neuroinflammation; 2014 Jul; 11():132. PubMed ID: 25065370
[TBL] [Abstract][Full Text] [Related]
18. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
[TBL] [Abstract][Full Text] [Related]
19. CCL2 binding is CCR2 independent in primary adult human astrocytes.
Fouillet A; Mawson J; Suliman O; Sharrack B; Romero IA; Woodroofe MN
Brain Res; 2012 Feb; 1437():115-26. PubMed ID: 22226505
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1β mediated amyloid plaque clearance is independent of CCR2 signaling in the APP/PS1 mouse model of Alzheimer's disease.
Rivera-Escalera F; Matousek SB; Ghosh S; Olschowka JA; O'Banion MK
Neurobiol Dis; 2014 Sep; 69():124-33. PubMed ID: 24874542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
